Analgesic Efficacy of "Burst" and Tonic (500 Hz) Spinal Cord Stimulation Patterns: A Randomized Placebo-Controlled Crossover Study.

Burst stimulation randomized double-blind crossover trial sham stimulation spinal cord stimulation tonic sub-threshold stimulation

Journal

Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159

Informations de publication

Date de publication:
Apr 2021
Historique:
revised: 29 10 2020
received: 20 09 2020
accepted: 31 10 2020
pubmed: 1 12 2020
medline: 19 8 2021
entrez: 30 11 2020
Statut: ppublish

Résumé

The aim of this study was to compare the efficacy in reducing pain intensity in adult subjects suffering from chronic back and leg pain of burst (BST) and tonic sub-threshold stimulation at 500 Hz (T500) vs. sham stimulation delivered by a spinal cord stimulation (SCS) device capable of automated postural adjustment of current intensity. A multicentre randomized double-blind, three-period, three-treatment, crossover study was undertaken at two centers in the United Kingdom. Patients who had achieved stable pain relief with a conventional SCS capable of automated postural adjustment of current intensity were randomized to sequences of BST, T500, and sham SCS with treatment order balanced across the six possible sequences. A current leakage was programmed into the implantable pulse generator (IPG) in the sham period. The primary outcome was patient reported pain intensity using a visual analog scale (VAS). Nineteen patients were enrolled and randomized. The mean reduction in pain with T500 was statistically significantly greater than that observed with either sham (25%; 95% CI, 8%-38%; p = 0.008) or BST (28%; 95% CI, 13%-41%; p = 0.002). There were no statistically significant differences in pain VAS for BST versus Sham (5%; 95% CI, -13% to 27%; p = 0.59). Exploratory sub-group analyses by study site and sex were also conducted for the T500 vs. sham and BST versus sham comparisons. The findings suggest a superior outcome versus sham from T500 stimulation over BST stimulation and a practical equivalence between BST and sham in a group of subjects with leg and back pain habituated to tonic SCS and having achieved a stable status with stimulation.

Identifiants

pubmed: 33251662
doi: 10.1111/ner.13321
pii: S1094-7159(21)00053-2
doi:

Substances chimiques

Analgesics 0

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-478

Subventions

Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom
Organisme : Medtronic funded the study through a grant to South Tees Hospitals
Organisme : The study was sponsored by South Tees Hospitals. Medtronic played no further role in study design, execution, data analysis or write up.

Informations de copyright

© 2020 International Neuromodulation Society.

Références

Kapural L, Yu C, Doust MW et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic Back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology 2015;123:851-860.
Deer T, Slavin KV, Amirdelfan K et al. Success using neuromodulation with BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform. Neuromodulation 2018;21:56-66.
Thomson SJ, Tavakkolizadeh M, Love-Jones S et al. Effects of rate on analgesia in kilohertz frequency spinal cord stimulation: results of the PROCO randomized controlled trial. Neuromodulation 2018;21:67-76.
De Andres J, Monsalve-Dolz V, Fabregat-Cid G et al. Prospective, randomized blind effect-on-outcome study of conventional vs high-frequency spinal cord stimulation in patients with pain and disability due to failed Back surgery syndrome. Pain Med 2017;18:2401-2421.
Perruchoud C, Eldabe S, Batterham AM et al. Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation 2013;16:363-369. discussion 9.
Kriek N, Groeneweg JG, Stronks DL, de Ridder D, Huygen FJ. Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. Eur J Pain 2017;21:507-519.
Schu S, Slotty PJ, Bara G, von Knop M, Edgar D, Vesper J. A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation 2014;17:443-450.
Duarte RV, McNicol E, Colloca L, Taylor RS, North RB, Eldabe S. Randomized placebo-/sham-controlled trials of spinal cord stimulation: a systematic review and methodological appraisal. Neuromodulation 2020;23:10-18.
Duarte RV, Nevitt S, McNicol E et al. Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain 2020;161:24-35.
Oswald AM, Chacron MJ, Doiron B, Bastian J, Maler L. Parallel processing of sensory input by bursts and isolated spikes. J Neurosci 2004;24:4351-4362.
Chacron MJ, Longtin A, Maler L. To burst or not to burst? J Comput Neurosci 2004;17:127-136.
Lisman JE. Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci 1997;20:38-43.
Swadlow HA, Gusev AG. The impact of 'bursting' thalamic impulses at a neocortical synapse. Nat Neurosci 2001;4:402-408.
Sherman SM. A wake-up call from the thalamus. Nat Neurosci 2001;4:344-346.
Dwan K, Li T, Altman DG, Elbourne D. CONSORT 2010 statement: extension to randomised crossover trials. BMJ 2019;366:l4378.
Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
Kirby S, Chuang-Stein C, Morris M. Determining a minimum clinically important difference between treatments for a patient-reported outcome. J Biopharm Stat 2010;20:1043-1054.
Julious SA. Sample sizes for clinical trials with normal data. Stat Med 2004;23:1921-1986.
Senn SS. Cross-over trials in clinical research. 1st ed. Chichester: Wiley, 1993.
Chow SC, Shao J, Wang H. Sample size calculations in clinical research. New York, NY: Marcel Dekker Inc, 2003.
Schulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet 2005;365:1591-1595.
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-1238.
Tjepkema-Cloostermans MC, de Vos CC, Wolters R, Dijkstra-Scholten C, Lenders MW. Effect of burst stimulation evaluated in patients familiar with spinal cord stimulation. Neuromodulation 2016;19:492-497.
Abejon D, Feler CA. Is impedance a parameter to be taken into account in spinal cord stimulation? Pain Physician 2007;10:533-540.
Schultz DM, Webster L, Kosek P, Dar U, Tan Y, Sun M. Sensor-driven position-adaptive spinal cord stimulation for chronic pain. Pain Physician 2012;15:1-12.

Auteurs

Sam Eldabe (S)

Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.

Rui Duarte (R)

Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK.

Ashish Gulve (A)

Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.

Heather Williams (H)

Department of Pain Management, Newcastle-upon-Tyne NHS Trust, Newcastle, UK.

Fay Garner (F)

Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.

Morag Brookes (M)

Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.

Grace Madzinga (G)

Department of Clinical Research Services, ICON Group, Sydney, Australia.

Eric Buchser (E)

Department of Anaesthesia and Pain Management, EHC - Hôpital de Morges, Morges, Switzerland.

Alan M Batterham (AM)

School of Health and Life Sciences, Teesside University, Middlesbrough, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH